Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00907244 · ClinicalTrials.gov registry record
Arterial Spin Labeling Perfusion Magnetic Resonance (MR) Imaging in Pediatric Brain Tumors
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 13
- Enrollment target
NCT00907244: Completed study, sponsored by Children's Hospital of Philadelphia.
NCT00907244 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00907244 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to get information regarding the usefulness and accuracy of this new magnetic resonance imaging (MRI) technique - termed arterial spin labeling (ASL) - in the diagnosis of pediatric brain tumors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-07 |
What the finished NCT00907244 record still lists
NCT00907244 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00907244 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00907244 about?
NCT00907244 is a clinical study titled "Arterial Spin Labeling Perfusion Magnetic Resonance (MR) Imaging in Pediatric Brain Tumors". The purpose of this study is to get information regarding the usefulness and accuracy of this new magnetic resonance imaging (MRI) technique - termed arterial spin labeling (ASL) - in the diagnosis of pediatric brain tumors.
What is the current status of trial NCT00907244?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2008-04. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT00907244?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia